Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
50 Results for ''
Translation News
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 2, 2024
Translation News
Ropirio launches from Wyss Institute to develop first-in-class lymphatic medicines
September 11, 2024
Awards
The Wyss Institute’s 2024-2025 Validation Projects
May 29, 2024
Translation News
Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University
May 15, 2024
Translation News
Plastic Degradation Company, Breaking, Emerges from Stealth with Naturally-Derived Solution to Degrade Multiple Plastics with $10.5M in Seed Funding
April 17, 2024
Translation News
Introducing the Wyss Lumineers Class of 2023
February 21, 2024
Community
Helping life-changing technologies leave the nest
February 9, 2024
Community
The Wyss Institute and Northpond Ventures’ relationship is moving full steam ahead
October 26, 2023
Translation News
The Wyss Institute’s 2023-2024 Validation Projects
October 19, 2023
Translation News
Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change
May 23, 2023
Press Release
Wyss Diagnostics Accelerator’s Industrial Participant Program goes official
April 13, 2023
Translation News
Wyss Lumineers Class of 2022 announced
January 25, 2023
Translation News
Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
December 19, 2022
Translation News
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
October 17, 2022
Translation News
Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases
June 24, 2022
Translation News
Wyss Technologies Top Harvard’s 2022 President’s Innovation Challenge
May 9, 2022
Translation News
From Patents to Products
April 26, 2022
Translation News
Cantex licenses intellectual property from Harvard University to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
February 23, 2022
Translation News
Harvard University licenses kidney engineering technology to Trestle Biotherapeutics to facilitate new kidney replacement therapies
February 22, 2022
Translation News
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
February 10, 2022
Translation News
Wyss Lumineers Class of 2021 Announced
January 24, 2022
Translation News
Pluto Biosciences launches from Harvard’s Wyss Institute to speed scientific discovery
August 16, 2021
Translation News
Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass. startup Rhinostics
May 4, 2021
Translation News
Introducing the Wyss Lumineers Class of 2020
February 24, 2021
Translation News
Harvard’s Wyss Institute collaborates with GBS Inc. on the Wyss’ eRapid-based COVID-19 diagnostic to help curb the pandemic
February 17, 2021
Translation News
Harvard’s Wyss Institute licenses its eRapid technology to The iQ Group Global to accelerate the development of COVID-19 diagnostics
November 30, 2020
Translation News
Harvard Wyss Institute’s nasal swab and toehold switch technologies licensed to Agile Biodetection to facilitate SARS-CoV-2 diagnostic efforts
October 5, 2020
Translation News
Metalmark launches to make clean air affordable for all
September 1, 2020
Translation News
Harvard’s Wyss Institute launches Torus Biosystems to pioneer its comprehensive infectious disease diagnostics platform at the patient point-of-care
August 21, 2020
Translation News
Wyss Institute’s tough gel technology licensed to Amend Surgical for oral surgery applications
July 21, 2020
Translation News
Rejuvenate Bio launches to help dogs live longer, healthier lives
February 6, 2020
Translation News
Wyss Institute and Miraki Innovation Unveil BOA Biomedical to Reduce Sepsis Deaths
September 10, 2019
Translation News
Harvard’s athlete-based next-generation probiotics technology licensed to FitBiomics
September 5, 2019
Translation News
Sherlock Biosciences Licenses Wyss Technology to Create Affordable Molecular Diagnostics
March 21, 2019
Translation News
Wyss Institute’s infant health-promoting technology licensed to Prapela
August 22, 2018
Translation News
Pig organs for human patients: A challenge fit for CRISPR
May 30, 2018
Translation News
Harvard’s Wyss Institute launches NuProbe to facilitate global precision medicine
April 23, 2018
Translation News
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
March 20, 2018
Translation News
Startup promises minimally invasive heart repair
March 15, 2018
Translation News
Harvard’s Wyss Institute launches Root Robotics, an educational startup to get anyone coding
August 8, 2017
Translation News
Wyss Institute launches ReadCoor to commercialize 3D
in situ
gene sequencing technology
September 28, 2016
Translation News
Harvard spinout Validere to commercialize “liquid fingerprinting” technique
August 4, 2016
Translation News
Wyss Institute collaborates with ReWalk Robotics to develop wearable exosuits for patients with limited mobility
May 17, 2016
Translation News
Harvard’s Wyss Institute launches Ultivue to facilitate super-resolution microscopy
October 13, 2015
Translation News
Wyss Institute launches startup to commercialize new sepsis therapy
October 8, 2015
Translation News
Wyss software licensed for hospital bedside data collection
July 22, 2015
Translation News
Broad Institute, Harvard and MIT license CRISPR-Cas9 technology to Editas Medicine for therapeutic applications
December 1, 2014
Translation News
Wyss Institute launches ‘SLIPS’ company
October 29, 2014
Translation News
Wyss Institute’s technology translation engine launches ‘Organs-on-Chips’ company
July 28, 2014
Translation News
Wyss Institute Signs Licensing Agreement with K-Team Corporation
November 17, 2011
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
